Gene · 1024
Papers2,191
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,081 to 1,100 of 2,191
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Characterizing CDK8/19 Inhibitors through a NFκB-Dependent Cell-Based Assay. | Cells | 2019 | 31590445 | PubTator, text mining | PubMed |
| Inhibition of Cdk8/Cdk19 Activity Promotes Treg Cell Differentiation and Suppresses Autoimmune Diseases. | Front Immunol | 2019 | 31552016 | PubTator, text mining | PubMed |
| Enhancement of therapeutic potential of mesenchymal stem cell-derived extracellular vesicles. | Stem Cell Res Ther | 2019 | 31547882 | PubTator, text mining | PubMed |
| Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes. | Toxicol Appl Pharmacol | 2019 | 31533062 | PubTator, text mining | PubMed |
| Understanding Obesity as a Risk Factor for Uterine Tumors Using Drosophila. | Adv Exp Med Biol | 2019 | 31520353 | PubTator, text mining | PubMed |
| A Screen of the Conserved Kinome for Negative Regulators of LIN-12 Negative Regulatory Region ("NRR")-Missense Activity in Caenorhabditis elegans. | G3 (Bethesda) | 2019 | 31519743 | PubTator, text mining | PubMed |
| Synthesis, molecular docking and biological potentials of new 2-(4-(2-chloroacetyl) piperazin-1-yl)-N-(2-(4-chlorophenyl)-4-oxoquinazolin-3(4H)-yl)acetamide derivatives. | BMC Chem | 2019 | 31517312 | PubTator, text mining | PubMed |
| POT1 and Damage Response Malfunction Trigger Acquisition of Somatic Activating Mutations in the VEGF Pathway in Cardiac Angiosarcomas. | J Am Heart Assoc | 2019 | 31510873 | PubTator, text mining | PubMed |
| CDK8 Regulates Insulin Secretion and Mediates Postnatal and Stress-Induced Expression of Neuropeptides in Pancreatic β Cells. | Cell Rep | 2019 | 31509750 | PubTator, text mining | PubMed |
| Regulation of Skn7-dependent, oxidative stress-induced genes by the RNA polymerase II-CTD phosphatase, Fcp1, and Mediator kinase subunit, Cdk8, in yeast. | J Biol Chem | 2019 | 31506296 | PubTator, text mining | PubMed |
| Mediator function in plant metabolism revealed by large-scale biology. | J Exp Bot | 2019 | 31504746 | PubTator, text mining | PubMed |
| Transcriptional Responses to IFN-γ Require Mediator Kinase-Dependent Pause Release and Mechanistically Distinct CDK8 and CDK19 Functions. | Mol Cell | 2019 | 31495563 | PubTator, text mining | PubMed |
| Wnt/β-Catenin Signaling: The Culprit in Pancreatic Carcinogenesis and Therapeutic Resistance. | Int J Mol Sci | 2019 | 31480221 | PubTator, text mining | PubMed |
| Human embryonic stem cells display a pronounced sensitivity to the cyclin dependent kinase inhibitor Roscovitine. | BMC Mol Cell Biol | 2019 | 31462218 | PubTator, text mining | PubMed |
| Mouse Model of Congenital Heart Defects, Dysmorphic Facial Features and Intellectual Developmental Disorders as a Result of Non-functional CDK13. | Front Cell Dev Biol | 2019 | 31440507 | PubTator, text mining | PubMed |
| Cytolytic activity correlates with the mutational burden and deregulated expression of immune checkpoints in colorectal cancer. | J Exp Clin Cancer Res | 2019 | 31429779 | PubTator, text mining | PubMed |
| E2F1 proteolysis via SCF-cyclin F underlies synthetic lethality between cyclin F loss and Chk1 inhibition. | EMBO J | 2019 | 31424118 | PubTator, text mining | PubMed |
| A Tyrosine Kinase Expression Signature Predicts the Post-Operative Clinical Outcome in Triple Negative Breast Cancers. | Cancers (Basel) | 2019 | 31412533 | PubTator, text mining | PubMed |
| A Pliable Mediator Acts as a Functional Rather Than an Architectural Bridge between Promoters and Enhancers. | Cell | 2019 | 31402173 | PubTator, text mining | PubMed |
| In-silico molecular design of heterocyclic benzimidazole scaffolds as prospective anticancer agents. | BMC Chem | 2019 | 31384837 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1024/papers?page=55